Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1501046

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1501046

Healthcare Contract Research Organization (CRO)

PUBLISHED:
PAGES: 89 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Global Healthcare Contract Research Organization (CRO) Market to Reach $74.9 Billion by 2030

The global market for Healthcare Contract Research Organization (CRO) estimated at US$52.1 Billion in the year 2023, is expected to reach US$74.9 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Clinical CRO, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$61.3 Billion by the end of the analysis period. Growth in the Pre-Clinical CRO segment is estimated at 5.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $15.8 Billion, While China is Forecast to Grow at 5% CAGR

The Healthcare Contract Research Organization (CRO) market in the U.S. is estimated at US$15.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$13.1 Billion by the year 2030 trailing a CAGR of 5% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 4.3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 33 Featured) -

  • Axcent Advanced Analytics (A3)
  • BIO Agile Therapeutics
  • Charles River Laboratories
  • Covance, Inc.
  • Firma Clinical Research
  • GVK Biosciences Private Limited
  • ICON, plc.
  • IQVIA
  • Medidata Solutions, Inc.
  • Medpace Holdings
  • Paraxel International
  • Pharmaceutical Product Development, LLC (PPD)
  • Pharmaron
  • PPD
  • PRA Health Sciences
  • PSI CRO AG
  • SGS
  • Syneos Health
Product Code: MCP21923

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Healthcare Contract Research Organization (CRO) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Healthcare Contract Research Organization (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Clinical Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Clinical Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Clinical Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Quality Management / Assurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Quality Management / Assurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Quality Management / Assurance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Project Management / Clinical Supply Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Project Management / Clinical Supply Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Project Management / Clinical Supply Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Regulatory / Medical Affairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Regulatory / Medical Affairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Regulatory / Medical Affairs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Healthcare Contract Research Organization (CRO) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
  • CHINA
    • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Healthcare Contract Research Organization (CRO) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030

IV. COMPETITION

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!